Gefitinib IP 250mg Tablets

Product Description

Product Name: Gefitinib IP 250mg Tablets

Product Form: Tablets

Pack Size: 30's

Manufactured By: MBA Pharmaceuticals

Used For:

• Non-Small Cell Lung Cancer (NSCLC): Gefitinib, also known as Gefitinib, is primarily used to treat advanced or metastatic non-small cell lung cancer (NSCLC) with specific mutations in the epidermal growth factor receptor (EGFR) gene.

Side Effects:

• Diarrhea: Common side effect, which can be severe in some cases.
• Skin Rash: Includes acne-like rash, dryness, or itching.
• Nausea and Vomiting: Gastrointestinal disturbances that can affect overall comfort.
• Fatigue: General feeling of tiredness or weakness.
• Liver Function Abnormalities: Elevated liver enzymes or jaundice, indicating liver issues.
• Loss of Appetite: Reduced desire to eat, potentially leading to weight loss.
• Dry Mouth: Reduced saliva production, causing a dry sensation in the mouth.
• Interstital Lung Disease (ILD): Rare but serious lung condition that may cause cough, difficulty breathing, and lung inflammation.

Precautions:

• Liver Function Monitoring: Regular monitoring of liver function tests is necessary due to potential liver toxicity.
• Drug Interactions: Inform your healthcare provider of all other medications and supplements you are taking, as Gefitinib can interact with various drugs.
• Pregnancy and Breastfeeding: Not recommended during pregnancy or breastfeeding due to potential risks to the fetus or infant.
• Pulmonary Symptoms: Monitor for any respiratory symptoms, as ILD can occur. Discontinue use if ILD symptoms develop.
• Renal Function: Use with caution in patients with renal impairment, and monitor kidney function if necessary.